Target intelligence / Profile preview

Thoracic sympathetic nerve

Molecular classification
Other (anatomical nerve fiber/nerve bundle, not receptor/enzyme/transporter)
01

Overview

The thoracic sympathetic nerves refer to a group of autonomic nerve fibers originating from the thoracic segments (T1–T12) of the spinal cord, forming the thoracic portion of the sympathetic trunk and sending branches such as the greater, lesser, and least thoracic splanchnic nerves. These nerves consist of preganglionic fibers that synapse in paravertebral ganglia or pass through to prevertebral ganglia, ultimately modulating autonomic (involuntary) activity in thoracic and abdominal organs such as the heart, lungs, blood vessels, and digestive tract. They function via neurotransmitter release (primarily norepinephrine and epinephrine) at effector sites and are fundamentally anatomical, not molecular entities[1][2][7][9].

Other names
Thoracic sympathetic trunkthoracic splanchnic nervessympathetic nerves of thoraxthoracic paravertebral ganglia
02

Mechanism of action

Inhibition of nerve conduction (nerve block); Modulation of adrenergic signaling (acting on neurotransmitter release or receptors at target organs)

03

Biological functions

Autonomic control of thoracic and some abdominal organsSignal transduction (via norepinephrine and epinephrine release at organ targets)Regulation of cardiovascular, respiratory, and digestive systems
04

Disease associations

Cardiovascular disease (e.g., arrhythmia modulation)Autonomic dysfunctionPheochromocytoma (overactivity of sympathetic system)Orthostatic hypotensionOther (sympathetic overactivity)
05

Safety considerations

Surgical or interventional disruption can cause adverse autonomic effects (e.g., cardiac arrhythmias, hypotension)Risk of collateral damage to adjacent anatomical structuresPotential for autonomic dysregulation
06

Interacting drugs

Drugs affecting sympathetic nervous system broadly (e.g., beta-blockers, alpha-blockers), but not direct molecular targeting of the nerves themselves

1 more in the full profile.

Beyond the preview

Go deeper on Thoracic sympathetic nerve.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thoracic sympathetic nerve.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call